Strategies for Antimicrobial Stewardship in Solid Organ Transplant Recipients

Area of Science:

• Transplant Medicine
• Infectious Diseases
• Pharmacology

Background:

• Antimicrobial therapy complications, including multidrug-resistant organisms and Clostridium difficile, pose significant risks to solid-organ transplant recipients.
• These complications are linked to increased graft loss and patient mortality.
• Despite numerous opportunities, antimicrobial stewardship practices in transplant patients are underreported.

Purpose of the Study:

• To highlight the need for improved antimicrobial stewardship in solid-organ transplant recipients.
• To emphasize the importance of a structured, multidisciplinary approach to antimicrobial therapy in this vulnerable population.
• To advocate for nuanced strategies that optimize antimicrobial use and protect both patients and antimicrobial efficacy.

Main Methods:

• Review of existing literature on antimicrobial complications in transplant recipients.
• Analysis of current antimicrobial stewardship practices.
• Conceptual framework development for a patient-centered, multidisciplinary approach.

Main Results:

• Complications of antimicrobial therapy are prevalent and severe in solid-organ transplant recipients.
• Existing antimicrobial stewardship efforts in this population are limited.
• A significant gap exists in the implementation of tailored antimicrobial stewardship programs.

Conclusions:

• A patient-centered, multidisciplinary antimicrobial stewardship program is essential for solid-organ transplant recipients.
• Established antimicrobial optimization principles should be adapted for nuanced application in transplant care.
• Such programs are vital for mitigating risks, preserving antimicrobial effectiveness, and improving patient and graft survival.